InMode Ltd. (NASDAQ:INMD) Shares Sold by Fmr LLC

Fmr LLC lowered its position in InMode Ltd. (NASDAQ:INMD) by 34.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,015 shares of the healthcare company’s stock after selling 12,000 shares during the quarter. Fmr LLC’s holdings in InMode were worth $390,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of INMD. Quantbot Technologies LP purchased a new stake in shares of InMode in the 3rd quarter valued at approximately $1,104,000. D.A. Davidson & CO. lifted its holdings in InMode by 10.5% in the third quarter. D.A. Davidson & CO. now owns 41,278 shares of the healthcare company’s stock valued at $700,000 after acquiring an additional 3,915 shares during the last quarter. Intech Investment Management LLC purchased a new position in InMode in the third quarter worth approximately $526,000. Thrivent Financial for Lutherans acquired a new stake in InMode during the third quarter worth $201,000. Finally, North Growth Management Ltd. increased its stake in InMode by 0.3% during the third quarter. North Growth Management Ltd. now owns 595,000 shares of the healthcare company’s stock worth $10,083,000 after acquiring an additional 2,000 shares during the last quarter. 68.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

INMD has been the subject of a number of research analyst reports. BTIG Research began coverage on InMode in a report on Thursday, October 17th. They set a “buy” rating and a $25.00 price target for the company. Barclays lowered their target price on shares of InMode from $29.00 to $27.00 and set an “overweight” rating for the company in a research note on Monday, October 14th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of InMode in a research report on Thursday, October 31st. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $22.60.

InMode Trading Up 0.2 %

INMD opened at $17.19 on Friday. The stock’s 50-day moving average price is $18.26 and its 200 day moving average price is $17.47. InMode Ltd. has a 12-month low of $14.87 and a 12-month high of $26.80. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 9.29 and a beta of 2.07.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.